Columbus Medical Gastroenterology Inc is categorized under Rheumatologists in Columbus, OH and active since 1995.
Columbus Medical Gastroenterology Inc was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact K Michael Taylor at the company’s single location by writing to 1211 Dublin Road Floor 2, Columbus, Ohio OH 43215 or by phoning (614) 486-5207. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Columbus Medical Gastroenterology Inc |
| Contact Person: | K Michael Taylor |
| Address: | 1211 Dublin Road Floor 2, Columbus, Ohio 43215 |
| Phone Number: | (614) 486-5207 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rheumatologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Columbus Medical Gastroenterology Inc was started in 1995 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact K Michael Taylor for inquiries that concern Columbus Medical Gastroenterology Inc by calling the company number (614) 486-5207, as your correspondence is most welcome. Additionally, the physical location of the single location of Columbus Medical Gastroenterology Inc can be found at the coordinates as well as the street address 1211 Dublin Road Floor 2 in Columbus, Ohio 43215.
For its online presence, you may visit Columbus Medical Gastroenterology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.